Rheumatology Drugs
Prescription drugs and medicines for conditions relating to joints, tendons, muscles, ligaments, and associated structures. Studies in this area include: arthritis, osteoarthritis, psoriasis, rheumatic fever, rheumatoid arthritis, and others.
The list of FDA approved drugs for rheumatology appears below. Click any link to view the full drug information.
For the treatment of rheumatoid arthritis
For the treatment of systemic juvenile idiopathic arthritis
Treatment for Rheumatoid Arthritis
Treatment for arthritis
Treatment for rheumatoid arthritis
Oral tablet for the treatment of osteoarthritis, rheumatoid arthritis and menstrual pain
For the treatment of rheumatoid arthritis
For gout flares and familial Mediterranean fever
For the relief of rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers
For the treatmenr of mucopolysaccharidosis II (Hunter Syndrome)
For the treatment of psoriatic arthritis
Generic equivalent of Lodine
Generic equivalent of Lodine
For the treatment of moderately to severely active rheumatoid arthritis
Generic equivalent or Oruvail
Injectable therapy for the treatment of rheumatoid arthritis
For the treatment of chronic gout (hyperuricemia)
Treatment for rheumatoid arthritis
Treatment for the signs and symptoms of osteoarthritis and rheumatoid arthritis
Treatment for arthritis
For relief of the signs and symptoms of osteoarthritis
Treatment for osteoarthritis and rheumatoid arthritis
For the treatment of Juvenile Idiopathic Arthritis
For the Treatment of Rheumatoid Arthritis
For the treatment of osteoarthritis of the knee
For the treatment of certain inflammatory diseases, including arthritis, COPD, asthma and psoriatic conditions
Intravenous infusion for the treatment of rheumatoid arthritis
For inhibiting the progression of structural damage in patients with rheumatoid arthritis
Treatment for Sjogren's Syndrome
For the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
For the treatment of erectile dysfunction
Joint fluid therapy for treatment of osteoarthritis in the knee
For the treatment of pain associated with osteoarthritis of the knee
Treatment for arthritis
For the treatment of chronic hyperuricemia in patients with gout
For the treatment of arthritis in patients at risk for NSAID-associated ulcers
For the treatment of rheumatoid arthritis
For the prevention of postmenopausal osteoporosis
FDA Approved Rheumatology Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA rheumatology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The rheumatology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
